Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.31 trillion and total revenue of $116.09 billion.
Market Cap
1.31T
Revenue
116.09B
Profits
-38.86B
PE Ratio
n/a
Profit Margin
-33.48%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.08B | -0.26% | 95,421 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.30B | -1.15% | 67,990 | 15.53B |
| 3 | ARGX | argenx SE | 61.97B | 0.45% | 43,860 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 58.52B | 7.29% | 6,095,329 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.14B | -1.01% | 321,007 | - |
| 6 | ONC | BeOne Medicines AG | 39.23B | 0.93% | 86,314 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.75B | -0.09% | 510,638 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.35B | 0.71% | 239,485 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.49B | -0.29% | 1,025,604 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.73B | -0.24% | 350,033 | 1.14B |
| 11 | INCY | Incyte Corporation | 24.75B | -0.95% | 181,102 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.44B | 0.91% | 492,178 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.41B | 0.99% | 312,923 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.33B | 1.03% | 49,729 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.93B | 2.04% | 91,174 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.15B | -0.19% | 269,179 | 713.07M |
| 17 | SMMT | Summit Therapeutics Inc. | 13.93B | 2.74% | 757,456 | - |
| 18 | EXEL | Exelixis, Inc. | 13.83B | -2.84% | 694,437 | 2.44B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.68B | -0.03% | 209,246 | 3.41B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.54B | 0.91% | 96,952 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | 0.24% | 47,118 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.10B | -0.38% | 158,975 | 1.66B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.95B | 2.20% | 222,263 | 669.50M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.74B | 6.17% | 391,088 | 776.57M |
| 25 | TECH | Bio-Techne Corporation | 11.34B | 0.31% | 878,673 | 1.22B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.38B | 1.53% | 27,047 | 440.48M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.36B | 1.24% | 349,076 | 67.67M |
| 28 | ABVX | ABIVAX Société Anonyme | 10.25B | 0.79% | 319,218 | 5.67M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.68B | -0.45% | 66,567 | 105.00M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.54B | 1.61% | 107,942 | 281.99M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.44B | -0.17% | 56,456 | 7.46M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.15B | -1.05% | 421,005 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 8.71B | -0.64% | 313,710 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.51B | 4.02% | 5,771,926 | 165.79M |
| 35 | TWST | Twist Bioscience Corporation | 7.96B | 0.10% | 378,279 | 431.80M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.78B | -0.48% | 123,092 | - |
| 37 | IMVT | Immunovant, Inc. | 7.74B | -1.65% | 138,916 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.73B | -1.68% | 203,101 | 799.54M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.16B | 1.76% | 123,048 | 239.92M |
| 40 | BLTE | Belite Bio, Inc | 7.14B | 1.26% | 41,957 | - |
| 41 | CAI | Caris Life Sciences, Inc. | 6.87B | 1.12% | 456,500 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 6.75B | -0.47% | 259,779 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.49B | -0.69% | 73,292 | 618.07M |
| 44 | CGON | CG Oncology, Inc. | 6.48B | 1.61% | 216,429 | 6.23M |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.35B | -0.26% | 180,084 | 591.33M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 6.14B | 1.16% | 105,952 | - |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.99B | 3.61% | 248,080 | 1.90M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.80B | -1.88% | 347,833 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.71B | 0.30% | 73,095 | 7.50M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.68B | -1.43% | 55,974 | 290.54M |
| 51 | ERAS | Erasca, Inc. | 5.62B | 0.19% | 730,088 | - |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.53B | -1.72% | 121,928 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.16B | 1.75% | 174,433 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.03B | -0.40% | 210,739 | 13.39M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.78B | - | 139,970 | 1.14B |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | 2.49% | 173,996 | - |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.57B | 1.82% | 58,789 | 148.00K |
| 58 | CELC | Celcuity Inc. | 4.15B | -0.68% | 100,551 | - |
| 59 | MANE | Veradermics, Incorporated | 4.14B | 1.03% | 129,807 | - |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.14B | - | 643,196 | 10.35M |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.07B | -1.16% | 139,839 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.07B | 3.17% | 189,099 | 53.81M |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.82B | -5.50% | 197,267 | 890.79M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.76B | 0.19% | 723,501 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.68B | -1.09% | 454,341 | 1.27B |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.68B | -0.31% | 2,814,797 | 324.97M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.61B | -0.11% | 52,572 | 234.13M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.54B | -0.51% | 75,748 | 606.33M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.40B | -0.68% | 167,581 | 3.60M |
| 70 | ABCL | AbCellera Biologics Inc. | 3.38B | -0.14% | 1,083,691 | 66.17M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.38B | -1.79% | 484,432 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.21B | -3.56% | 711,633 | 117.00M |
| 73 | QURE | uniQure N.V. | 3.10B | 0.40% | 192,324 | 18.67M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.02B | 2.78% | 288,361 | 463.98M |
| 75 | CLDX | Celldex Therapeutics, Inc. | 2.95B | -1.39% | 261,828 | 158.00K |
| 76 | MBX | MBX Biosciences, Inc. | 2.87B | -2.25% | 54,116 | - |
| 77 | IMNM | Immunome, Inc. | 2.83B | -0.16% | 128,264 | 4.02M |
| 78 | PHVS | Pharvaris N.V. | 2.81B | 6.78% | 466,057 | - |
| 79 | GPCR | Structure Therapeutics Inc. | 2.73B | -3.21% | 147,301 | - |
| 80 | ATAI | AtaiBeckley Inc. | 2.73B | - | - | 4.47M |
| 81 | ZLAB | Zai Lab Limited | 2.70B | -0.33% | 235,391 | 449.61M |
| 82 | IRON | Disc Medicine, Inc. | 2.67B | -6.08% | 119,776 | - |
| 83 | NRIX | Nurix Therapeutics, Inc. | 2.66B | -0.79% | 231,333 | 36.77M |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | -3.48% | 2,115,493 | - |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.59B | 0.14% | 84,174 | - |
| 86 | NAMS | NewAmsterdam Pharma Company N.V. | 2.54B | -2.70% | 224,821 | 7.12M |
| 87 | VERA | Vera Therapeutics, Inc. | 2.46B | 1.61% | 1,339,740 | - |
| 88 | PGEN | Precigen, Inc. | 2.44B | 2.02% | 404,822 | 85.72M |
| 89 | BEAM | Beam Therapeutics Inc. | 2.42B | -0.70% | 298,451 | 156.04M |
| 90 | VRDN | Viridian Therapeutics, Inc. | 2.41B | -4.44% | 115,921 | 71.13M |
| 91 | NKTR | Nektar Therapeutics | 2.40B | -0.41% | 83,141 | 54.59M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 0.36% | 144,581 | 959.90M |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.34B | 0.33% | 503,925 | 52.06M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.29B | 1.07% | 896,550 | - |
| 95 | PVLA | Palvella Therapeutics, Inc. | 2.17B | 0.25% | 27,135 | - |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 0.10% | 257,841 | 1.97B |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | 0.25% | 113,842 | 311.51M |
| 98 | NUVB | Nuvation Bio Inc. | 2.12B | -3.66% | 961,467 | 169.90M |
| 99 | ADMA | ADMA Biologics, Inc. | 2.10B | -0.37% | 308,576 | 512.28M |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.09B | 0.28% | 32,365 | 20.00M |
| 101 | URGN | UroGen Pharma Ltd. | 2.08B | 0.84% | 112,327 | 188.73M |
| 102 | KOD | Kodiak Sciences Inc. | 2.08B | 0.73% | 69,489 | - |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 0.77% | 110,060 | 1.00M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | 1.61% | 210,986 | 98.34M |
| 105 | MESO | Mesoblast Limited | 2.00B | - | 27,925 | 120.25M |
| 106 | GENB | Generate Biomedicines, Inc. | 1.99B | 0.71% | 121,592 | 26.48M |
| 107 | BHVN | Biohaven Ltd. | 1.96B | 1.64% | 678,827 | - |
| 108 | VCEL | Vericel Corporation | 1.92B | -0.84% | 60,538 | 306.30M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.90B | 0.48% | 66,880 | 27.59M |
| 110 | COAG | Hemab Therapeutics Holdings, Inc. | 1.87B | 0.55% | 56,013 | - |
| 111 | GHRS | GH Research PLC | 1.87B | -0.05% | 20,001 | - |
| 112 | ZYME | Zymeworks Inc. | 1.87B | -0.42% | 78,027 | 37.13M |
| 113 | KLRA | Kailera Therapeutics, Inc. | 1.85B | -4.29% | 118,652 | - |
| 114 | NBTX | Nanobiotix S.A. | 1.85B | -2.47% | 33,914 | 38.27M |
| 115 | XNCR | Xencor, Inc. | 1.79B | -0.87% | 176,456 | 104.97M |
| 116 | SEPN | Septerna, Inc. | 1.78B | 1.14% | 112,360 | 98.88M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.78B | -0.52% | 469,067 | 303.23M |
| 118 | LKFT | Lakefront Biotherapeutics NV | 1.76B | 0.30% | 76,034 | 1.13B |
| 119 | DMRA | Damora Therapeutics, Inc. | 1.74B | 5.25% | 62,846 | - |
| 120 | KARD | Kardigan, Inc. | 1.74B | -0.70% | 73,264 | - |
| 121 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.72B | -1.49% | 710,340 | 208.78M |
| 122 | IMCR | Immunocore Holdings plc | 1.71B | -1.31% | 64,354 | 430.78M |
| 123 | BRVE | Braveheart Bio, Inc. | 1.71B | -2.46% | 70,930 | - |
| 124 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -0.27% | 2,378,407 | 54.86M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.66B | -0.97% | 865,543 | 59.51M |
| 126 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | -1.74% | 293,385 | 5.49M |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 1.65B | -1.89% | 230,857 | 252.25M |
| 128 | ANAB | AnaptysBio, Inc. | 1.64B | 0.21% | 61,700 | 232.39M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.62B | -1.18% | 70,852 | 1.30M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.62B | - | 240,688 | 2.68B |
| 131 | NVAX | Novavax, Inc. | 1.59B | 3.56% | 2,202,817 | 413.80M |
| 132 | AVLN | Avalyn Pharma Inc. | 1.54B | 0.14% | 18,203 | - |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.50B | -2.08% | 43,147 | - |
| 134 | INVA | Innoviva, Inc. | 1.48B | -0.53% | 104,948 | 440.00M |
| 135 | AAPG | Ascentage Pharma Group International | 1.47B | -3.36% | 4,330 | 94.61M |
| 136 | LBRX | LB Pharmaceuticals Inc | 1.47B | -1.45% | 42,341 | - |
| 137 | LTGO | Latigo Biotherapeutics, Inc. | 1.44B | 0.97% | 23,244 | - |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.42B | 0.93% | 273,908 | - |
| 139 | ABSI | Absci Corporation | 1.41B | -0.30% | 425,585 | 1.56M |
| 140 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -1.15% | 46,372 | - |
| 141 | RARE | Ultragenyx Pharmaceutical Inc. | 1.40B | -1.28% | 557,557 | 717.00M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.38B | -0.14% | 598,938 | 20.00M |
| 143 | SVRA | Savara Inc. | 1.35B | -0.09% | 258,554 | - |
| 144 | OMER | Omeros Corporation | 1.35B | 0.27% | 230,354 | 38.42M |
| 145 | VOR | Vor Biopharma Inc. | 1.34B | 1.52% | 170,213 | - |
| 146 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | -1.31% | 138,851 | - |
| 147 | AKTS | Aktis Oncology, Inc. | 1.32B | -0.88% | 40,685 | 10.06M |
| 148 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | -4.48% | 108,142 | - |
| 149 | DRTS | Alpha Tau Medical Ltd. | 1.30B | -2.84% | 100,281 | - |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | 0.91% | 142,268 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 1.12% | 32,148 | - |
| 152 | ANRO | Alto Neuroscience, Inc. | 1.25B | 0.63% | 68,922 | - |
| 153 | MGTX | MeiraGTx Holdings plc | 1.24B | 0.16% | 94,652 | 397.50M |
| 154 | ALMS | Alumis Inc. | 1.21B | -5.35% | 749,314 | 7.40M |
| 155 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -1.01% | 196,507 | 28.73M |
| 156 | IMTX | Immatics N.V. | 1.20B | 0.69% | 144,528 | 47.65M |
| 157 | MNKD | MannKind Corporation | 1.20B | -1.32% | 392,773 | 393.63M |
| 158 | JBIO | Jade Biosciences, Inc. | 1.20B | -1.75% | 425,028 | - |
| 159 | SLBT | SL Science Holding Limited | 1.19B | -0.95% | 16,635 | 3.27M |
| 160 | REPL | Replimune Group, Inc. | 1.18B | -5.74% | 979,558 | - |
| 161 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 2.88% | 31,443 | 99.00K |
| 162 | OBX | Obsidian Therapeutics, Inc. | 1.13B | 6.24% | 111,675 | - |
| 163 | MLTX | MoonLake Immunotherapeutics | 1.11B | -0.68% | 653,744 | - |
| 164 | APMD | Apnimed, Inc. | 1.11B | -0.56% | 54,258 | 120.15M |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -0.23% | 426,355 | - |
| 166 | JANX | Janux Therapeutics, Inc. | 1.05B | -2.57% | 128,463 | 24.00M |
| 167 | ATTO | Attovia Therapeutics, Inc. | 1.02B | -0.44% | 39,524 | 1.80M |
| 168 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.49% | 312,370 | 181.72M |
| 169 | KURA | Kura Oncology, Inc. | 1.01B | -1.64% | 452,240 | 77.23M |
| 170 | ANL | Adlai Nortye Group Ltd. | 1.00B | 3.25% | 47,212 | 18.06M |
| 171 | FTH | Faeth Therapeutics, Inc. | 1.00B | -0.54% | 98,811 | - |
| 172 | SLDB | Solid Biosciences Inc. | 957.52M | -1.54% | 197,391 | - |
| 173 | HELP | Cybin Inc. | 955.62M | 1.87% | 374,686 | - |
| 174 | IVA | Inventiva S.A. | 932.40M | -4.59% | 380,156 | 7.94M |
| 175 | SGP | SpyGlass Pharma, Inc. | 925.67M | 1.34% | 59,722 | - |
| 176 | SANA | Sana Biotechnology, Inc. | 911.55M | -1.46% | 531,290 | - |
| 177 | DSGN | Design Therapeutics, Inc. | 909.31M | -1.82% | 138,305 | - |
| 178 | AVTX | Avalo Therapeutics, Inc. | 907.69M | -1.48% | 311,631 | 59.00K |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 904.73M | -3.27% | 126,738 | - |
| 180 | WVE | Wave Life Sciences, Inc. | 903.47M | -1.82% | 531,312 | 65.37M |
| 181 | ARDX | Ardelyx, Inc. | 900.81M | -0.14% | 654,947 | 450.89M |
| 182 | TBPH | Theravance Biopharma, Inc. | 884.18M | 0.06% | 73,756 | 104.31M |
| 183 | LXRX | Lexicon Pharmaceuticals, Inc. | 883.24M | -1.73% | 1,408,764 | 41.47M |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 880.10M | -0.35% | 28,953 | 276.79M |
| 185 | IMMX | Immix Biopharma, Inc. | 874.93M | -3.70% | 308,302 | - |
| 186 | GERN | Geron Corporation | 867.34M | -1.46% | 1,070,096 | 204.56M |
| 187 | CLYM | Climb Bio, Inc. | 856.66M | -0.23% | 277,403 | - |
| 188 | CBIO | Crescent Biopharma, Inc. | 839.76M | 0.82% | 45,469 | 11.88M |
| 189 | SLN | Silence Therapeutics plc | 789.65M | -1.47% | 134,670 | 615.00K |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 773.53M | -4.54% | 686,111 | 8.22M |
| 191 | PHAR | Pharming Group N.V. | 761.51M | 4.67% | 3,971 | 366.48M |
| 192 | CADL | Candel Therapeutics, Inc. | 759.83M | -12.36% | 1,572,826 | - |
| 193 | ANNX | Annexon, Inc. | 757.37M | -3.50% | 1,467,777 | - |
| 194 | MPLT | MapLight Therapeutics, Inc. | 754.72M | -1.49% | 57,533 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 740.38M | -1.17% | 226,254 | - |
| 196 | MNPR | Monopar Therapeutics Inc. | 738.83M | 0.10% | 12,673 | - |
| 197 | NVCT | Nuvectis Pharma, Inc. | 729.83M | -0.40% | 8,596 | - |
| 198 | FDMT | 4D Molecular Therapeutics, Inc. | 728.67M | -2.22% | 86,080 | 92.01M |
| 199 | GYRE | Gyre Therapeutics, Inc. | 722.55M | 1.10% | 17,522 | 109.82M |
| 200 | DBVT | DBV Technologies S.A. | 720.55M | -3.32% | 322,753 | 5.04M |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 718.54M | 0.33% | 96,494 | 136.07M |
| 202 | AURA | Aura Biosciences, Inc. | 718.16M | -0.93% | 254,250 | - |
| 203 | CTMX | CytomX Therapeutics, Inc. | 716.89M | -1.79% | 395,515 | 18.30M |
| 204 | NGNE | Neurogene Inc. | 716.01M | -0.94% | 25,132 | 925.00K |
| 205 | SGMT | Sagimet Biosciences Inc. | 680.02M | -1.08% | 118,789 | - |
| 206 | OCS | Oculis Holding AG | 677.82M | -2.92% | 56,851 | 1.45M |
| 207 | AGMB | AgomAb Therapeutics NV | 669.28M | -2.51% | 45,252 | - |
| 208 | MDXG | MiMedx Group, Inc. | 666.13M | -0.65% | 94,421 | 355.17M |
| 209 | VSTM | Verastem, Inc. | 666.09M | -3.48% | 302,715 | 87.53M |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 645.36M | -2.09% | 58,071 | - |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 643.38M | -3.23% | 283,422 | 239.66M |
| 212 | ALT | Altimmune, Inc. | 640.94M | 0.15% | 633,430 | 31.00K |
| 213 | VALN | Valneva SE | 635.68M | -1.20% | 25,646 | 163.30M |
| 214 | DRUG | Bright Minds Biosciences Inc. | 633.24M | -2.16% | 65,604 | - |
| 215 | CRMD | CorMedix Inc. | 624.33M | 0.63% | 168,929 | 462.25M |
| 216 | ASMB | Assembly Biosciences, Inc. | 623.85M | 0.59% | 57,299 | 74.85M |
| 217 | STTK | Shattuck Labs, Inc. | 618.74M | 0.24% | 150,129 | 1.00M |
| 218 | ALLO | Allogene Therapeutics, Inc. | 609.34M | 0.21% | 986,614 | 4.64M |
| 219 | OABI | OmniAb, Inc. | 593.19M | 3.29% | 220,784 | 38.46M |
| 220 | PROK | ProKidney Corp. | 572.90M | 2.99% | 176,841 | 818.00K |
| 221 | SCTX | Scribe Therapeutics Inc. | 572.02M | 2.53% | 40,744 | 33.30M |
| 222 | PRME | Prime Medicine, Inc. | 571.06M | -4.18% | 845,152 | 4.07M |
| 223 | TECX | Tectonic Therapeutic, Inc. | 568.89M | 1.71% | 29,663 | - |
| 224 | RGNX | REGENXBIO Inc. | 567.05M | 0.35% | 194,561 | 174.48M |
| 225 | ARVN | Arvinas, Inc. | 558.40M | -1.95% | 121,000 | 316.70M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 554.91M | 0.61% | 31,779 | - |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 528.45M | 3.74% | 106,245 | - |
| 228 | OVID | Ovid Therapeutics Inc. | 518.52M | 0.95% | 267,290 | 1.58M |
| 229 | ZURA | Zura Bio Limited | 507.89M | -1.49% | 220,299 | - |
| 230 | IRD | Opus Genetics, Inc. | 505.83M | 0.16% | 1,584,911 | 9.86M |
| 231 | AUTL | Autolus Therapeutics plc | 501.72M | -3.83% | 445,123 | 117.39M |
| 232 | SPRY | ARS Pharmaceuticals, Inc. | 495.75M | -1.48% | 352,480 | 116.93M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 495.26M | -2.78% | 73,248 | 251.00K |
| 234 | EIKN | Eikon Therapeutics, Inc. | 492.36M | -1.30% | 193,874 | - |
| 235 | ENTX | Entera Bio Ltd. | 491.72M | 1.79% | 61,826 | 42.00K |
| 236 | PRLD | Prelude Therapeutics Incorporated | 483.05M | 0.43% | 190,514 | 22.42M |
| 237 | CAPR | Capricor Therapeutics, Inc. | 482.55M | - | 539,637 | 11.13M |
| 238 | RLMD | Relmada Therapeutics, Inc. | 467.75M | 7.74% | 789,041 | - |
| 239 | PBYI | Puma Biotechnology, Inc. | 462.00M | -2.40% | 84,270 | 231.24M |
| 240 | PRTA | Prothena Corporation plc | 459.21M | -0.83% | 77,927 | 54.53M |
| 241 | CABA | Cabaletta Bio, Inc. | 458.62M | -1.28% | 1,028,808 | - |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 449.60M | -1.09% | 383,588 | - |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 441.08M | -3.39% | 252,014 | 132.42M |
| 244 | RZLT | Rezolute, Inc. | 438.76M | 0.72% | 275,237 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 430.59M | 2.94% | 156,977 | 35.04M |
| 246 | AVIR | Atea Pharmaceuticals, Inc. | 426.69M | 2.70% | 236,566 | - |
| 247 | VOGX | Vogenx, Inc. | 426.16M | 2.55% | 42,028 | - |
| 248 | IKT | Inhibikase Therapeutics, Inc. | 426.06M | 0.43% | 52,973 | 1.00 |
| 249 | BNTC | Benitec Biopharma Inc. | 421.01M | 0.29% | 17,780 | - |
| 250 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 416.91M | -5.80% | 430,935 | - |
| 251 | ARCT | Arcturus Therapeutics Holdings Inc. | 416.68M | 4.86% | 135,480 | 29.37M |
| 252 | EDIT | Editas Medicine, Inc. | 413.90M | 1.70% | 724,070 | 47.01M |
| 253 | LRMR | Larimar Therapeutics, Inc. | 406.57M | 1.17% | 861,939 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 404.30M | 2.13% | 3,734 | 36.84M |
| 255 | GALT | Galectin Therapeutics Inc. | 393.31M | - | 71,850 | - |
| 256 | TTRX | Turn Therapeutics Inc. | 390.82M | -1.94% | 24,221 | - |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 383.81M | -3.14% | 72,705 | 59.22M |
| 258 | EVMN | Evommune, Inc. | 382.34M | -0.24% | 74,269 | 10.00M |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 369.27M | -0.17% | 60,898 | 65.26M |
| 260 | EYPT | EyePoint, Inc. | 368.99M | 0.71% | 767,575 | 2.79M |
| 261 | INDP | Indaptus Therapeutics, Inc. | 367.75M | 7.81% | 1,001,251 | - |
| 262 | CMPX | Compass Therapeutics, Inc. | 364.68M | -1.22% | 463,418 | 850.00K |
| 263 | OBIO | Orchestra BioMed Holdings, Inc. | 363.64M | 4.13% | 171,755 | 31.98M |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 362.26M | -5.17% | 424,883 | - |
| 265 | PALI | Palisade Bio, Inc. | 361.61M | 3.23% | 916,702 | 500.00K |
| 266 | OCGN | Ocugen, Inc. | 356.07M | 2.44% | 1,824,826 | 4.58M |
| 267 | SION | Sionna Therapeutics, Inc. | 354.47M | 2.89% | 272,572 | - |
| 268 | LXEO | Lexeo Therapeutics, Inc. | 351.14M | -1.83% | 79,910 | - |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 347.82M | -0.31% | 39,239 | - |
| 270 | IPSC | Century Therapeutics, Inc. | 344.04M | -2.06% | 95,106 | 109.16M |
| 271 | ZNTL | Zentalis Pharmaceuticals, Inc. | 331.35M | -2.51% | 141,525 | 26.87M |
| 272 | XFOR | X4 Pharmaceuticals, Inc. | 329.17M | -2.35% | 219,870 | 15.85M |
| 273 | QTTB | Q32 Bio Inc. | 321.96M | 0.89% | 177,925 | 53.74M |
| 274 | UPB | Upstream Bio, Inc. | 312.19M | -0.87% | 85,130 | 3.16M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 312.08M | 0.29% | 559,409 | 114.70K |
| 276 | ABEO | Abeona Therapeutics Inc. | 310.80M | -0.82% | 285,801 | 25.52M |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 306.85M | 0.69% | 137,903 | 215.72M |
| 278 | AGEN | Agenus Inc. | 306.14M | -1.31% | 288,836 | 132.69M |
| 279 | IFRX | InflaRx N.V. | 305.79M | 1.22% | 49,586 | -11.54K |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 305.08M | -3.13% | 230 | 412.09K |
| 281 | LYEL | Lyell Immunopharma, Inc. | 294.55M | -1.48% | 21,116 | 27.00K |
| 282 | CUVL | Clinuvel Pharmaceuticals Limited | 290.76M | -1.36% | 1,127 | 65.05M |
| 283 | FULC | Fulcrum Therapeutics, Inc. | 289.93M | - | 89,590 | 80.00M |
| 284 | STRO | Sutro Biopharma, Inc. | 284.62M | -3.73% | 36,940 | 45.70M |
| 285 | IMRX | Immuneering Corporation | 284.02M | -3.94% | 179,805 | - |
| 286 | FATE | Fate Therapeutics, Inc. | 277.98M | -0.43% | 327,126 | 6.49M |
| 287 | YDES | YD Bio Limited | 274.25M | - | 400,613 | 510.36K |
| 288 | ALXO | ALX Oncology Holdings Inc. | 271.02M | 3.16% | 252,985 | - |
| 289 | CAMP | Camp4 Therapeutics Corporation | 269.84M | -0.92% | 24,524 | 4.22M |
| 290 | BCYC | Bicycle Therapeutics plc | 269.12M | 0.39% | 123,366 | 61.21M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 268.67M | 5.34% | 12,425 | 1.48M |
| 292 | ACIU | AC Immune SA | 268.45M | 0.37% | 28,851 | 21.67M |
| 293 | PRQR | ProQR Therapeutics N.V. | 268.13M | -2.06% | 138,490 | 21.05M |
| 294 | PYXS | Pyxis Oncology, Inc. | 263.57M | -3.36% | 212,467 | 11.04M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 263.08M | -1.34% | 74,963 | 36.74M |
| 296 | LCTX | Lineage Cell Therapeutics, Inc. | 255.44M | -0.98% | 173,921 | 13.08M |
| 297 | MGNX | MacroGenics, Inc. | 254.80M | 0.76% | 79,958 | 175.14M |
| 298 | AVXL | Anavex Life Sciences Corp. | 251.67M | 2.07% | 107,965 | - |
| 299 | TRDA | Entrada Therapeutics, Inc. | 240.86M | 4.05% | 36,101 | 4.69M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 240.29M | 3.56% | 84,796 | 7.15M |
| 301 | ALEC | Alector, Inc. | 235.60M | -1.40% | 150,185 | 13.86M |
| 302 | CGEN | Compugen Ltd. | 233.97M | 0.41% | 46,006 | 74.00M |
| 303 | IVVD | Invivyd, Inc. | 232.92M | 1.84% | 1,395,607 | 58.37M |
| 304 | VRXA | Veraxa Biotech AG | 231.91M | -0.61% | 23,197 | 29.54K |
| 305 | CLLS | Cellectis S.A. | 231.45M | -0.16% | 16,993 | 63.82M |
| 306 | NGEN | NervGen Pharma Corp. | 230.64M | -0.69% | 100,382 | - |
| 307 | SRZN | Surrozen, Inc. | 228.08M | -0.23% | 23,591 | 11.51M |
| 308 | TARA | Protara Therapeutics, Inc. | 227.52M | 1.58% | 150,615 | - |
| 309 | GLSI | Greenwich LifeSciences, Inc. | 226.19M | 2.32% | 9,830 | - |
| 310 | ADAG | Adagene Inc. | 224.26M | 0.91% | 89,296 | 9.29M |
| 311 | ELDN | Eledon Pharmaceuticals, Inc. | 223.69M | -1.08% | 111,286 | - |
| 312 | KROS | Keros Therapeutics, Inc. | 221.27M | -0.09% | 21,071 | 15.01M |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 220.34M | 0.76% | 4,085 | 1.80M |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 218.35M | -0.73% | 46,762 | 80.62M |
| 315 | MSLE | Satellos Bioscience Inc. | 213.88M | 1.64% | 7,520 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 212.25M | 2.62% | 33,776 | - |
| 317 | ANTX | AN2 Therapeutics, Inc. | 209.44M | -2.46% | 3,542 | - |
| 318 | NKTX | Nkarta, Inc. | 208.43M | 3.56% | 111,834 | - |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 207.78M | -1.34% | 115,171 | 29.10M |
| 320 | NMRA | Neumora Therapeutics, Inc. | 207.62M | -3.07% | 242,783 | - |
| 321 | PEPG | PepGen Inc. | 207.43M | -0.83% | 51,426 | - |
| 322 | CHRS | Coherus Oncology, Inc. | 206.26M | -0.37% | 173,352 | 50.94M |
| 323 | ARMP | Armata Pharmaceuticals, Inc. | 203.76M | 4.78% | 6,943 | 5.54M |
| 324 | CUE | Cue Biopharma, Inc. | 203.37M | -0.02% | 26,514 | 37.66M |
| 325 | ACOG | Alpha Cognition Inc. | 199.81M | 3.09% | 8,004 | 15.26M |
| 326 | NERV | Minerva Neurosciences, Inc. | 198.87M | 0.12% | 15,934 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 196.76M | -0.63% | 44,646 | 2.00M |
| 328 | DTIL | Precision BioSciences, Inc. | 196.50M | -1.67% | 44,046 | 45.06M |
| 329 | VYGR | Voyager Therapeutics, Inc. | 195.64M | -0.47% | 63,006 | 34.46M |
| 330 | KRRO | Korro Bio, Inc. | 194.82M | 1.30% | 21,884 | 2.38M |
| 331 | NBP | NovaBridge Biosciences | 189.66M | -3.25% | 46,922 | - |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 174.10M | 1.63% | 149,629 | 1.50M |
| 333 | RNA | Atrium Therapeutics, Inc. | 173.62M | -1.93% | 53,826 | 35.84M |
| 334 | IPHA | Innate Pharma S.A. | 173.11M | 0.84% | 2,878 | 10.57M |
| 335 | MDWD | MediWound Ltd. | 173.00M | -2.26% | 8,127 | 11.86M |
| 336 | OTLK | Outlook Therapeutics, Inc. | 161.64M | 0.42% | 1,110,285 | -1.16M |
| 337 | CDXS | Codexis, Inc. | 160.43M | 1.74% | 74,673 | 77.68M |
| 338 | IMUX | Immunic, Inc. | 158.41M | -1.94% | 65,885 | - |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 157.59M | -1.12% | 113,578 | - |
| 340 | MOLN | Molecular Partners AG | 156.35M | -0.71% | 42 | 856.30K |
| 341 | HUMA | Humacyte, Inc. | 156.15M | -0.88% | 1,069,354 | 2.12M |
| 342 | SPRB | Spruce Biosciences, Inc. | 155.40M | -0.52% | 55,265 | 697.00K |
| 343 | MENS | Jyong Biotech Ltd. | 152.18M | 1.99% | 24,785 | - |
| 344 | KZIA | Kazia Therapeutics Limited | 148.48M | -1.59% | 76,517 | 1.27M |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 147.22M | -0.47% | 251,189 | - |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 146.66M | -0.29% | 117,385 | 3.39M |
| 347 | MIST | Milestone Pharmaceuticals Inc. | 146.55M | -0.95% | 315,150 | 2.34M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 146.03M | 0.38% | 257,347 | 1.34M |
| 349 | LENZ | LENZ Therapeutics, Inc. | 145.48M | -1.91% | 124,186 | 21.48M |
| 350 | CRBU | Caribou Biosciences, Inc. | 143.40M | -2.36% | 842,303 | 10.04M |
| 351 | EQ | Equillium, Inc. | 140.13M | -8.68% | 232,663 | 4.39M |
| 352 | HURA | TuHURA Biosciences, Inc. | 130.96M | 1.23% | 51,488 | - |
| 353 | NAUT | Nautilus Biotechnology, Inc. | 130.44M | 3.58% | 308,208 | 190.00K |
| 354 | OKUR | OnKure Therapeutics, Inc. | 129.99M | -1.83% | 29,613 | - |
| 355 | CNTB | Connect Biopharma Holdings Limited | 129.41M | -0.24% | 198,721 | 2.95M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 128.73M | -2.73% | 1,025,518 | 65.34K |
| 357 | TLSA | Tiziana Life Sciences Ltd | 127.06M | 1.93% | 34,596 | - |
| 358 | BMEA | Biomea Fusion, Inc. | 126.48M | 2.65% | 467,776 | - |
| 359 | CBUS | Cibus, Inc. | 121.14M | - | 16,464 | 4.35M |
| 360 | ENGN | enGene Therapeutics Inc. | 120.58M | 1.69% | 198,014 | - |
| 361 | CNXU | Conexeu Sciences Inc. | 118.81M | 4.47% | 44,294 | - |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 117.44M | 2.49% | 135,726 | 4.88M |
| 363 | PMN | ProMIS Neurosciences, Inc. | 117.03M | -2.61% | 6,288 | - |
| 364 | AARD | Aardvark Therapeutics, Inc. | 115.66M | 5.49% | 130,887 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 113.92M | 1.16% | 143,279 | 70.00M |
| 366 | VANI | Vivani Medical, Inc. | 113.66M | 0.80% | 138,059 | - |
| 367 | GNLX | Genelux Corporation | 109.79M | -1.21% | 34,811 | 8.00K |
| 368 | TENX | Tenax Therapeutics, Inc. | 109.41M | -2.05% | 910,597 | - |
| 369 | PMVP | PMV Pharmaceuticals, Inc. | 107.98M | -0.69% | 121,605 | - |
| 370 | SEER | Seer, Inc. | 107.98M | 1.04% | 21,506 | 14.22M |
| 371 | COYA | Coya Therapeutics, Inc. | 104.61M | -1.34% | 39,055 | 8.02M |
| 372 | PYPD | PolyPid Ltd. | 104.20M | -0.58% | 31,238 | - |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 103.68M | 4.52% | 6,079 | - |
| 374 | ACET | Adicet Bio, Inc. | 102.26M | -0.31% | 18,215 | - |
| 375 | GUTS | Fractyl Health, Inc. | 102.11M | -0.25% | 186,746 | 3.00K |
| 376 | ONCY | Oncolytics Biotech Inc. | 96.41M | -2.06% | 514,969 | - |
| 377 | ANIX | Anixa Biosciences, Inc. | 96.12M | 2.73% | 64,505 | - |
| 378 | ATRA | Atara Biotherapeutics, Inc. | 95.66M | -3.64% | 4,165 | 6.19M |
| 379 | CGTX | Cognition Therapeutics, Inc. | 94.63M | 1.58% | 105,218 | - |
| 380 | CRDF | Cardiff Oncology, Inc. | 92.19M | -2.07% | 143,073 | 508.00K |
| 381 | ICCC | ImmuCell Corporation | 89.14M | -1.01% | 3,531 | 30.68M |
| 382 | RLYB | Rallybio Corporation | 88.95M | - | 2,036 | 646.00K |
| 383 | MNOV | MediciNova, Inc. | 88.84M | 3.74% | 12,067 | 920.48K |
| 384 | NTHI | NeOnc Technologies Holdings, Inc. | 88.74M | -2.46% | 13,848 | 39.99K |
| 385 | PTHS | Pelthos Therapeutics Inc. | 87.60M | 2.01% | 7,454 | 43.30M |
| 386 | ALDX | Aldeyra Therapeutics, Inc. | 86.87M | -1.37% | 328,338 | - |
| 387 | VRCA | Verrica Pharmaceuticals Inc. | 85.03M | - | 4,320 | 30.32M |
| 388 | FBIO | Fortress Biotech, Inc. | 84.71M | -1.17% | 80,070 | 68.47M |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 84.42M | -3.43% | 64,434 | - |
| 390 | KLRS | Kalaris Therapeutics, Inc. | 80.94M | 3.03% | 22,725 | - |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | -1.69% | 14,364 | - |
| 392 | NTRB | Nutriband Inc. | 79.01M | 6.91% | 11,186 | 1.62M |
| 393 | OSTX | OS Therapies Incorporated | 77.96M | -7.14% | 379,659 | - |
| 394 | IBIO | iBio, Inc. | 77.81M | -1.22% | 59,966 | 100.00K |
| 395 | MAIA | MAIA Biotechnology, Inc. | 77.25M | -3.05% | 156,745 | - |
| 396 | BSEM | BioStem Technologies, Inc. | 77.19M | 3.58% | 55,241 | 34.59M |
| 397 | RNXT | RenovoRx, Inc. | 77.17M | -3.39% | 362,803 | 1.98M |
| 398 | OKYO | OKYO Pharma Limited | 76.13M | 1.45% | 1,104 | - |
| 399 | GANX | Gain Therapeutics, Inc. | 75.29M | 0.88% | 43,931 | - |
| 400 | YARW | Yarrow Bioscience, Inc. | 74.82M | -6.05% | 356,758 | - |
| 401 | CING | Cingulate Inc. | 73.51M | -2.22% | 12,575 | - |
| 402 | PLRX | Pliant Therapeutics, Inc. | 72.14M | 3.10% | 47,899 | - |
| 403 | ATHE | Alterity Therapeutics Limited | 72.09M | 2.43% | 10,036 | 2.50M |
| 404 | NRXS | NeurAxis, Inc. | 71.33M | -0.18% | 30,547 | 5.32M |
| 405 | CSBR | Champions Oncology, Inc. | 70.58M | -0.30% | 6,319 | 60.66M |
| 406 | LONA | LeonaBio, Inc. | 67.93M | 5.10% | 38,152 | - |
| 407 | XBIT | XBiotech Inc. | 66.92M | 1.15% | 4,869 | - |
| 408 | RNTX | Rein Therapeutics Inc. | 66.87M | -0.74% | 39,378 | - |
| 409 | GOSS | Gossamer Bio, Inc. | 66.42M | -4.58% | 192,097 | 53.29M |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 66.29M | 3.72% | 5,173 | - |
| 411 | SPRO | Spero Therapeutics, Inc. | 65.81M | 0.89% | 115,207 | 47.00M |
| 412 | ALPS | Alps Group Inc | 65.71M | 2.60% | 83,905 | 3.74M |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 65.07M | -0.98% | 5,470 | - |
| 414 | EDSA | Edesa Biotech, Inc. | 64.98M | 3.20% | 5,445 | - |
| 415 | BOLD | Boundless Bio, Inc. | 64.15M | -0.70% | 40,011 | - |
| 416 | INMB | INmune Bio Inc. | 63.83M | -0.43% | 87,558 | 50.00K |
| 417 | INKT | MiNK Therapeutics, Inc. | 63.58M | 2.72% | 39,495 | - |
| 418 | HYFT | MindWalk Holdings Corp. | 61.79M | -0.38% | 16,482 | 11.43M |
| 419 | SER | Serina Therapeutics, Inc. | 61.22M | -3.60% | 25,482 | 130.00K |
| 420 | EXOZ | eXoZymes, Inc. | 59.91M | 4.62% | 2,692 | -700.00 |
| 421 | HRTX | Heron Therapeutics, Inc. | 59.80M | -2.26% | 383,508 | 151.18M |
| 422 | XLO | Xilio Therapeutics, Inc. | 59.42M | 1.12% | 1,031 | 64.09M |
| 423 | IMMP | Immutep Limited | 59.19M | 11.90% | 2,053,432 | 13.79M |
| 424 | ELTX | Elicio Therapeutics, Inc. | 57.56M | 3.79% | 160,226 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 57.42M | 2.92% | 241,464 | 1.40M |
| 426 | IMA | ImageneBio, Inc. | 56.87M | 0.10% | 644 | 800.00K |
| 427 | IBO | Impact BioMedical Inc. | 52.83M | 11.11% | 100,408 | 35.00K |
| 428 | MCRB | Seres Therapeutics, Inc. | 51.10M | 0.78% | 9,533 | 1.88M |
| 429 | TIL | Instil Bio, Inc. | 50.86M | 1.90% | 611 | - |
| 430 | APLM | Apollomics, Inc. | 50.18M | -4.23% | 1,841 | 8.84M |
| 431 | ANVS | Annovis Bio, Inc. | 50.06M | -1.26% | 461,284 | - |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 47.70M | -0.71% | 302,918 | 21.00M |
| 433 | GRCE | Grace Therapeutics, Inc. | 47.12M | -0.88% | 40,905 | - |
| 434 | TVGN | Tevogen Inc. | 46.75M | -1.51% | 562 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 44.95M | 2.59% | 24,819 | 13.56M |
| 436 | MREO | Mereo BioPharma Group plc | 43.98M | 12.59% | 1,329,825 | 500.00K |
| 437 | VERU | Veru Inc. | 42.03M | -1.40% | 109,512 | 16.89M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 41.66M | 1.15% | 90,949 | 35.09M |
| 439 | ATYR | aTyr Pharma, Inc. | 41.39M | -2.29% | 260,459 | 190.00K |
| 440 | CELU | Celularity Inc. | 41.10M | -1.05% | 72,573 | 26.55M |
| 441 | CRVO | CervoMed Inc. | 38.25M | 2.02% | 46,231 | 331.30K |
| 442 | FLNA | Filana Therapeutics, Inc. | 37.98M | -2.79% | 108,547 | - |
| 443 | LITS | Lite Strategy, Inc. | 37.77M | 4.72% | 137,181 | - |
| 444 | NXTC | NextCure, Inc. | 34.70M | 3.69% | 26,740 | - |
| 445 | KYNB | Kyntra Bio, Inc. | 33.41M | 3.45% | 6,175 | 4.62M |
| 446 | CNTX | Context Therapeutics Inc. | 33.20M | -1.39% | 306,436 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.53M | -2.25% | 7,085 | 31.52M |
| 448 | BYSI | BeyondSpring Inc. | 32.05M | 1.64% | 49,933 | 1.88M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 31.42M | 3.33% | 30,061 | - |
| 450 | ESLA | Estrella Immunopharma, Inc. | 30.68M | 4.79% | 932 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 30.16M | 2.38% | 2,003 | - |
| 452 | IGC | IGC Pharma, Inc. | 29.57M | 1.06% | 99,065 | 1.11M |
| 453 | KPTI | Karyopharm Therapeutics Inc. | 29.37M | -20.06% | 3,671,705 | 146.62M |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 29.29M | 2.37% | 3,656 | - |
| 455 | ACTU | Actuate Therapeutics, Inc. | 27.14M | -1.74% | 133,515 | - |
| 456 | QNTM | Quantum BioPharma Ltd. | 26.57M | -0.15% | 46,740 | - |
| 457 | CVM | CEL-SCI Corporation | 26.56M | -0.66% | 10,323 | - |
| 458 | EVAX | Evaxion A/S | 26.44M | 2.26% | 11,140 | 7.49M |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.43M | 0.50% | 7,616 | 797.92K |
| 460 | RADX | Radiopharm Theranostics Limited | 24.89M | -0.13% | 8,450 | 9.34M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 24.41M | -0.27% | 5,207 | - |
| 462 | ATOS | Atossa Therapeutics, Inc. | 24.25M | 3.84% | 7,009 | - |
| 463 | PLRZ | Polyrizon Ltd. | 23.87M | 1.02% | 569 | - |
| 464 | COCP | Cocrystal Pharma, Inc. | 23.69M | - | 22,646 | 330.00K |
| 465 | JSPR | Jasper Therapeutics, Inc. | 23.34M | 0.11% | 20,388 | - |
| 466 | NNVC | NanoViricides, Inc. | 22.89M | -1.47% | 57,112 | - |
| 467 | CLRB | Cellectar Biosciences, Inc. | 22.21M | -0.84% | 1,974 | - |
| 468 | GRDX | GridAI Technologies Corp. | 22.16M | 5.39% | 59,623 | - |
| 469 | LTRN | Lantern Pharma Inc. | 21.99M | -2.27% | 31,039 | - |
| 470 | LGVN | Longeveron Inc. | 21.84M | 3.16% | 21,779 | 1.19M |
| 471 | AKTX | Akari Therapeutics, Plc | 21.21M | 0.14% | 23,084 | - |
| 472 | TCRX | TScan Therapeutics, Inc. | 21.07M | -2.20% | 350,907 | 7.11M |
| 473 | PTN | Palatin Technologies, Inc. | 20.94M | -0.25% | 14,794 | 12.88M |
| 474 | MRKR | Marker Therapeutics, Inc. | 20.76M | 3.75% | 997 | 3.55M |
| 475 | ALLR | Allarity Therapeutics, Inc. | 20.37M | 2.40% | 88,445 | 345.00K |
| 476 | NEUP | Neuphoria Therapeutics Inc. | 20.21M | 0.27% | 16,560 | -13.27K |
| 477 | PBM | Psyence Biomedical Ltd. | 19.11M | 0.80% | 29,210 | - |
| 478 | LPCN | Lipocine Inc. | 18.79M | 1.30% | 1,517 | 1.57M |
| 479 | NCEL | NewcelX Ltd. | 18.67M | -4.37% | 2,041 | - |
| 480 | CNSY | Cerenome, Inc. | 18.63M | 2.72% | 26,557 | 4.20M |
| 481 | CMMB | Chemomab Therapeutics Ltd. | 18.55M | -1.54% | 4,081 | - |
| 482 | DYAI | Dyadic International, Inc. | 18.24M | 2.23% | 19,628 | 3.80M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 18.20M | 0.89% | 18,803 | - |
| 484 | ENLV | Enlivex Ltd. | 17.66M | 2.99% | 82,995 | - |
| 485 | AEON | AEON Biopharma, Inc. | 17.25M | 19.28% | 17,974,791 | - |
| 486 | NIKI | Niki BioSolutions, Inc. | 17.07M | -6.74% | 8,754 | - |
| 487 | MBRX | Moleculin Biotech, Inc. | 16.98M | 5.02% | 361,939 | - |
| 488 | PDSB | PDS Biotechnology Corporation | 16.96M | -3.87% | 2,538,700 | - |
| 489 | BCDA | BioCardia, Inc. | 16.58M | -0.45% | 50,454 | 3.00K |
| 490 | PASG | Passage Bio, Inc. | 16.06M | 0.10% | 823 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.95M | -0.72% | 11,252 | 7.11M |
| 492 | ADIL | Adial Pharmaceuticals, Inc. | 15.76M | 0.08% | 5,700 | - |
| 493 | PLUR | Pluri Inc. | 15.74M | 2.01% | 1,226 | 1.02M |
| 494 | MLEC | Moolec Science SA | 15.09M | -1.83% | 1,288 | 7.83M |
| 495 | LSTA | Lisata Therapeutics, Inc. | 14.87M | 0.61% | 35,881 | 100.00K |
| 496 | BIVI | BioVie Inc. | 14.86M | 3.14% | 97,268 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.49M | -1.67% | 3,927 | 129.73K |
| 498 | CALC | CalciMedica, Inc. | 14.20M | -1.89% | 1,921 | - |
| 499 | TPST | Tempest Therapeutics, Inc. | 14.18M | 10.53% | 647,246 | - |
| 500 | ICU | SeaStar Medical Holding Corporation | 13.86M | 0.48% | 11,538 | 1.71M |